95 related articles for article (PubMed ID: 24322021)
21. Expression of stem cell markers nestin and cytokeratin 15 and 19 in cutaneous malignancies.
Abbas O; Bhawan J
J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):311-6. PubMed ID: 20629844
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
23. Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.
Baltaziak M; Duraj E; Koda M; Wincewicz A; Musiatowicz M; Kanczuga-Koda L; Szymanska M; Lesniewicz T; Musiatowicz B
Ann N Y Acad Sci; 2006 Dec; 1090():18-25. PubMed ID: 17384243
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
25. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
26. P53 and hMSH2 expression in basal cell carcinomas and malignant melanomas from photoexposed areas of head and neck region.
Staibano S; Lo Muzio L; Pannone G; Somma P; Farronato G; Franco R; Bambini F; Serpico R; De Rosa G
Int J Oncol; 2001 Sep; 19(3):551-9. PubMed ID: 11494035
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
28. Pituitary tumor-transforming gene 1 as a proliferation marker lacking prognostic value in cutaneous squamous cell carcinoma.
Ishitsuka Y; Kawachi Y; Taguchi S; Maruyama H; Nakamura Y; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Otsuka F
Exp Dermatol; 2013 May; 22(5):318-22. PubMed ID: 23489647
[TBL] [Abstract][Full Text] [Related]
29. Expression of Bax and apoptosis-related proteins in human esophageal squamous cell carcinoma including dysplasia.
Kurabayashi A; Furihata M; Matsumoto M; Ohtsuki Y; Sasaguri S; Ogoshi S
Mod Pathol; 2001 Aug; 14(8):741-7. PubMed ID: 11504832
[TBL] [Abstract][Full Text] [Related]
30. [Expression of bcl-2, bax and p53 protein in the basal cell carcinoma].
Yan L; Chen M; Yu G
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):179-80. PubMed ID: 11938785
[TBL] [Abstract][Full Text] [Related]
31. [Immunomorphological features of cutaneous basal-cell carcinoma].
Chuprov IN
Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of Fas and FasL pro-apoptotic proteins in basal cell and squamous cell carcinomas.
Wang XY; Zhang R; Lian S
Clin Exp Dermatol; 2011 Jan; 36(1):69-76. PubMed ID: 20497185
[TBL] [Abstract][Full Text] [Related]
33. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
34. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.
Sarbia M; Stahl M; Fink U; Willers R; Seeber S; Gabbert HE
Clin Cancer Res; 1998 Dec; 4(12):2991-7. PubMed ID: 9865911
[TBL] [Abstract][Full Text] [Related]
35. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
36. Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer.
Young LC; Listgarten J; Trotter MJ; Andrew SE; Tron VA
Br J Dermatol; 2008 Jan; 158(1):59-69. PubMed ID: 17970804
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR
J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of Bax and Bcl-2 in penile carcinoma.
Saeed S; Keehn CA; Khalil FK; Morgan MB
Ann Clin Lab Sci; 2005; 35(1):91-6. PubMed ID: 15830715
[TBL] [Abstract][Full Text] [Related]
39. Bcl-XL protein is markedly decreased in UVB-irradiated basal cell carcinoma cell lines through proteasome-mediated degradation.
Park K; Lee JH
Oncol Rep; 2009 Mar; 21(3):689-92. PubMed ID: 19212627
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
